The internet has revolutionized the accessibility of information about stem cells, but it also presents challenges in discerning reliable sources from misinformation. The way information is filtered and presented online is constantly changing. Now the arrival of AI adds to the complexity.
Bringing together research excellence to harness the therapeutic potential in stem cell medicine
Professor and CEO
reNEW – a unique global research center in stem cell medicine
reNEW is an international consortium of three leading research institutions in Denmark, Australia and the Netherlands, led by renowned Professor and CEO Melissa Little. We strive to advance a new generation of effective and safe stem cell-based therapies, built on a global collaborative network of excellence in targeted biomedical research.
Translating research into new stem cell medicine
The aim of the center is to strengthen the pathway from stem cell discovery research to clinical outcomes. We will apply our understanding of stem cells to improve drug development and deliver novel cell and tissue therapies.
Meet the scientists of reNEW
Leading scientists from around the globe collaborate to transform the world of stem cell medicine
Understanding stem cells and how they can be used
A stem cell can renew itself and generate other cell types. We all rely on stem cells to exist and to survive. Understanding stem cells and their potential has long been of interest to researchers across the globe. Stem cell medicine refers to the application of that understanding to accelerate the development of new therapies for people living with incurable diseases.
Be part of transformative science
Join us in delivering the next generation of effective and safe stem cell-based therapies. reNEW is situated in three places – Copenhagen, Leiden and Melbourne. But no matter where in the world you are, you can help us transform the future of stem cell medicine.
Impacting the world with our science
Find out the latest in the world of stem cell medicine.
Traditional laboratory models do not accurately replicate the human gut. This is a challenge for research on gut health in general and probiotics in particular.
Using lab-grown kidney tissue made from human stem cells, researchers across Melbourne have, for the first time, been able show how SARS-CoV-2 enters and directly infects the kidney cells.